Hyponatremia (HN) is defined as serum sodium \<135 mmol/L. It is a frequent finding in children with community-acquired pneumonia (CAP) (30% to 45%) ([@CIT0001]). Depending on plasma osmolality, HN \<135 mmol/L may be classified into pseudohyponatremia due to hyperproteinemia or hyperlypidemia (if plasma osmolality is 275 to 290 mOsm/L) or real HN (if plasma osmolality is \<275 mOsm/L). HN associated with low urinary sodium is usually related to excess of water. HN associated with high urinary sodium (\>40 mMol/L) is usually associated with an excess of antidiuretic hormone.

A few series of cases of children with CAP have attributed HN to syndrome of inappropriate antidiuretic hormone secretion (SIADH) ([@CIT0002]). SIADH is a syndrome characterized by euvolemic HN, with inadequate urinary secretion of sodium, high urine sodium concentrations and high fractional secretion of sodium. The pathophysiology of HN in several patients with CAP remains elusive ([@CIT0005]).

HN is observed in other febrile and acute inflammatory diseases, suggesting a relationship between HN and inflammation ([@CIT0006]). Inflammatory markers found in children with bacterial diseases as bacterial CAP include C-reactive protein and procalcitonin.

The aim of this study was to determine the proportion of SIADH among patients with CAP and HN. We also investigated the relationship between HN and inflammatory markers, bacterial etiology and prognosis in hospitalized children with CAP.

METHODS {#s5}
=======

Study design {#s6}
------------

This observational, multicentre, prospective cohort study was conducted at two centres in Madrid, Spain, from February, 2012, to March, 2015. This study is nested in a broader research by the name of Etiology of Pediatric Community-Acquired Pneumonia (PCAPE), approved by the Ethics Committee of Hospital Universitario Ramón y Cajal. Informed consent was obtained from the guardians of all children.

Collection of data {#s7}
------------------

The main researchers from each centre recorded and collected the study data. Two authors, EO and AT, analyzed the data in this study. We ensured patient confidentiality by employing a codification system.

Participants {#s8}
------------

Eligible participants were 1-month-old to 17-year-old children hospitalized due to CAP in Hospital Universitario Ramón y Cajal, from April 2012, to March 2015, and Hospital Universitario Infanta Sofía, from February 2014, to March 2015. CAP was defined as fever and an infiltrate in the chest x-ray. Pneumonia was identified by the attending physician and confirmed after recruitment by one blinded, senior radiologist. Exclusion criteria from the study were the following: immunosupressive conditions, chronic cardio-pulmonary disease (except asthma), hospitalization 30 days before admission, tuberculosis, malignancy, suspected foreign body aspiration, renal, thyroidal, adrenal insufficiency, and patients with medication that could alter sodium levels (except for prednisolone for asthma exacerbations).

Criteria for hospitalization were the following: infants less than 6 months old, poor feeding, clinical dehydration evaluated by the attending physician, electrolyte disturbance, respiratory or hemodynamic instability, SatO~2~ ≤ 92% with FiO2=0.21, altered state of conscientiousness, apnea, pulmonary complication (necrosis, abscess and significant pleural effusion), multifocal consolidation, failure of oral antimicrobials after 48 hours, or poor adherence to treatment.

HN was defined as serum sodium \<135 mmol/L. Essential criteria for SIADH were plasma osmolality \<275 mOsm/kg, urine sodium \>40 mmol/L and clinical euvolemia without edema or dehydration ([@CIT0009]). Dehydration was evaluated attending skin turgor, urinary output, tears and mouth saliva. Additional criteria were urinary osmolality \>100 mOsm/kg and fractional sodium excretion (FENa) \>1%.

Laboratory methods {#s9}
------------------

We measured serum sodium at admission, before administration of any intravenous solution. We used an indirect potentiometry method with Integrated Multisensor QuikLYTE (Dade Behring, Deerfield, IL, USA). Serum osmolality was calculated from the equation: (serum sodium ×2) +(urea/5.6)+(glucose/18) miliosmoles per kg. Correcting serum sodium levels for serum proteins was calculated from the equation: Corrected Sodium = Serum Sodium + \[(total proteins \[mg/L\]×10)-8 × 0.025\] ([@CIT0010]).

An extensive microbiological work-up was performed to determine etiology. Blood was cultured using the BacT/ALERT^®^ 3D blood culture system (bioMérieux, Marcy L'Etoile, France) or BacTec® 9240 blood culture system (Becton, Dickinson and Company, USA). *Streptococcus pneumoniae* antigen in pleural fluid (BinaxNow) was added if thoracentesis was performed. Pleural fluid was cultured by standard methods. PCR for *S pneumoniae* was carried out in blood. PCR multiplex was performed in nasopharyngeal aspirate for 16 viruses. These viruses were respiratory syncytial virus (RSV), human metapneumovirus (hMPV), parainfluenzae (PIV; 1, 2, 3 and 4), influenza (A and B), human bocavirus (hBoV), adenovirus (ADV), enterovirus (EV), human rhinovirus (hRV), and coronavirus (CoV; 229E, OC43, NL63 y HKU12). PCR was carried out for *M pneumoniae* and *C pneumoniae* in nasopharyngeal aspirate. Serology for *M pneumoniae*, *C pneumoniae* and *L pneumophila* was performed throughout enzyme immunoassay.

Definition of etiological agent {#s10}
-------------------------------

We determined that the detected microorganism was the causal etiology of CAP, with a high probability in the following cases: bacterial growth in blood culture or pleural fluid, *S pneumoniae* antigen in pleural fluid, positive PCR in blood, a fourfold increase in the IgG serology in serial samples, positive PCR in nasopharyngeal exudate for atypical bacteria, and positive PCR in nasopharyngeal exudate for RSV, hMPV, influenza A and B and PIV.

Data collection and variables {#s11}
-----------------------------

We collected data starting from July 2015. We examined the patients' medical records, and data were gathered into a confidential database. Basal features, laboratory values and immunization data were recorded. The principal investigator and biostatistician handled the database exclusively.

The primary endpoint was HN, defined as serum sodium \<135 mmol/L. We studied the following potential predictors as independent variables: C-reactive protein (CRP), procalcitonin (PCT), white blood cell (WBC) count (× 10^9^/L), neutrophils (× 10^9^/L), lobar pneumonia, typical bacterial etiology (*S pneumoniae, S aureus, S pyogenes, Haemophilus*), pneumococcal etiology, days of admission, days of oxygen, days of antibiotherapy, age, days of fever before admission, vomiting, clinically evaluated dehydration, severity of pneumonia according to WHO classification, chest x-ray pattern (consolidation end-point according to WHO classification), urea, serum sodium, urinary sodium and fraction of sodium excretion. We studied the following outcomes: complicated pneumonia, total days of fever, Paediatric Intensive Care Unit (PICU) admission, days of oxygen, high flow oxygen therapy, mechanical ventilation, severe acute respiratory syndrome (SARS), total days of antibiotics and days of hospitalization.

Statistical analysis {#s12}
--------------------

Categorical variables are presented with (both absolute and relative) frequency distributions. A descriptive analysis of the sample was performed. The continuous variables are expressed as the mean ± standard deviation (SD) or the median and interquartile range (IQR: Q1 to Q3) according to the Kolmogorov-Smirnov normality test. In order to compare the categorical variables, we employed a χ^2^ test or Fisher's exact test if there were ≤5 items of data in 20% of cells. Continuous variables were analyzed using the parametric Student's t-test, or the nonparametric Mann--Whitney U test. All statistical tests were two-tailed. All P-values less than 0.05 were considered significant. Odds ratio (OR) with a 95% CI was used to assess association of HN with features considered as secondary variables.

Spearman's test was performed in order to study the linear correlations. Simple regression analyses were developed, provided that the assumptions of simple linear regression were verified using graphics of residuals. Outliers were reported and included in the analyses. Goodness of fit was determined with the correlation coefficient, 95% CI and P-value, the coefficient of determination (r^2^) and P-value, and the residual and outlier assessment, the standard deviation of the residuals (Sy.x).

To predict the occurrence of HN, we performed a univariate and a multivariate, conditional logistic regression analysis model. We included all variables associated with an increased likelihood of HN in the univariate analysis. A significance level of 0.1 was used. An intro, simultaneous regression model was built, and then checked with forward and backward models. Explanatory variables were assessed for interaction and co-linearity, and goodness of fit was calculated. The statistical analysis was performed with SPSS 19.1 (SAS Institute, IBM Inc, USA).

RESULTS {#s13}
=======

A total of 240 eligible children were admitted to the hospital during the study period, and 169 of these children were recruited for the study. In the end, a total of 150 children were analyzed ([Figure 1](#F1){ref-type="fig"}). Median levels of serum sodium were 136 (IQR: 134 to 138) mmol/L, median plasma osmolality was 281 (IQR: 279 to 285) mOsm/kg, median CRP was 59 (IQR: 30 to 151) mg/L and median PCT was 0.32 (IQR: 0.11 to 1.82) ng/mL.

![Flowchart of the study. Only 5 out of 150 (3%) patients with community acquired pneumonia (CAP) had probable or possible syndrome of inappropriate antidiuretic hormone secretion.](pxy00301){#F1}

A total of 45 (30%) of 150 patients had HN with serum sodium \<135 mmol/L. Among them, 5 (3%) of 150 patients had serum sodium \<130 mmol/L. No patient had symptoms attributable to HN.

Features of children with and without HN can be found in [Table 1](#T1){ref-type="table"}. Patients with HN showed significantly higher levels of CRP, PCT, WBC and neutrophils and significantly lower levels of plasma osmolality and urine sodium. They had a significantly worse outcome, longer hospitalization and more days of fever. Moderate to severe HN (\<130 mmol/L) was associated with typical bacteria (P\<0.001, OR 25 \[95% CI 3.5 to 184\]).

###### 

Features of children with hyponatremia (HN) \<135 mmol/L vs. children without HN at admission. All continuous variables are presented as median and Interquartile Range (Q1--Q3) due to a non-normal distribution. Comparisons are all X2 or U of Mann Whitney.

  Feature                             HN (n=45)           No HN (n=105)       P value   Odds ratio for HN (95% CI)
  ----------------------------------- ------------------- ------------------- --------- ----------------------------
  Serum Sodium (mmol/L)               133 (132--134)      137 (136--138)      \<0.001   N/A
  Age (months)                        41 (22--76)         38 (18--70)         0.46      N/A
  Male---n (%)                        29 (64)             52 (49)             0.09      1.8 (0.8--3.7)
  Previous fever (days)               3 (1--5)            3 (1--5)            0.67      N/A
  Temperature (°C)                    37.7 (37.2--38.5)   37.5 (36.8--38.4)   0.17      N/A
  Breathing rate (bpm)                36 (22--50)         35 (23--46)         0.82      N/A
  Vomiting---n (%)                    20 (44)             35 (33)             0.19      1.6 (0.7--3.2)
  Clinical dehydration---n (%)        4 (9)               4 (4)               0.2       2 (0.5--10)
  Lobar consolidation---n (%)         41 (91)             87 (82)             0.19      2.1 (0.6--6.6)
  SatO2\<92%---n (%)                  8 (13.3)            25 (27)             0.09      N/A
  CRP (mg/L)                          135 (54--266)       49 (21--96)         \<0.001   N/A
  CRP \>100 mg/L---n (%)              29 (65)             25 (23)             \<0.001   6.1 (2.8--13.3)
  PCT (ng/mL)                         1.6 (0.2--10.4)     0.19 (0.09--0.64)   \<0.001   N/A
  PCT \>1.5 (ng/mL)---n (%)           16 (50)             13 (16)             \<0.001   5.2 (2.1--13)
  WBC × 109/L                         19.5 (12.0--26.9)   13.1 (9.2--17.8)    \<0.001   N/A
  WBC \>15---n (%)                    28 (63)             36 (34)             0.001     3.3 (1.6--6.9)
  Neutrophils × 109 /L                14.4 (9.2--22.0)    8.7 (5.1--13.7)     \<0.001   N/A
  Neutrophils \>10 × 109 /L---n (%)   38 (86)             47 (44)             \<0.001   7.8 (3--20)
  Serum glucose (mg/dL)               94 (83--118)        98 (86--120)        0.18      N/A
  Calculated osmolality (mosmol/kg)   274 (270--279)      283 (280--286)      \<0.001   N/A
  Sodium in urine (mmol/L)            23 (1--71)          72 (40--118)        \<0.001   N/A
  Admission (days)                    6 (5--8)            5 (4--7)            0.041     N/A
  Total days of fever                 1 (1--2.5)          1 (1)               0.001     N/A
  FENa \<1%---n (%)                   25 (56)             68 (64)             0.40      1.2 (0.3--4.8)
  Antibiotics (days)                  10 (10--11.5)       10 (8--14)          0.29      N/A
  Oxygen (days)                       0 (0--2)            0 (0--3)            0.07      N/A
  Pulmonary complication---n (%)      12 (26)             32 (30)             0.63      0.8 (0.3--1.8)
  PICU---n (%)                        5 (11)              14 (13)             0.70      0.8 (0.2--2.4)
  High Flow Ventilation---n (%)       4 (9)               13 (12)             0.5       0.6 (0.2--2.2)
  Mechanical ventilation---n (%)      0                   1 (1)               0.51      N/A
  SARS---n (%)                        2 (4)               2 (2)               0.37      2.3 (0.3--17.5)
  Typical bacteria---n (%)            5 (15)              4 (5)               0.05      3.6 (0.9--14.0)
  Viral only---n (%)                  21 (65)             52 (63)             0.82      1.1 (0.4--2.5)
  Atypical bacteria---n (%)           6 (18)              26 (31)             0.16      0.49 (0.1--1.3)
  WHO category II-III---n (%)         14 (31)             49 (46)             0.07      0.5 (0.2--1.1)
  Hemoglobin (g/dL)                   12.1 (11.2--13.2)   12.4 (11.1--13.2)   0.52      N/A
  Creatinin (mg/dL)                   0.44 (0.32--0.57)   0.49 (0.40--0.53)   0.28      N/A

*CRP C-reactive protein; HN Hyponatremia; PCT Procalcitonin; PICU Paediatric Intensive Care Unit; SARS Severe Acute Respiratory Syndrome; WBC White blood cell*.

Of the 45 patients with serum sodium levels \<135 mmol/L, we wanted to determine the number of patients who had true, hypo-osmolar HN. We excluded 10 patients who lacked serum proteins data. Of the remaining 35 patients with HN, we corrected for hyperglycemia and protein levels, and only 22 (62%) of these 35 patients had true HN. Thirteen patients (29% of the initial 45 patients with HN) had true, hypo-osmolar HN ([Figure 1](#F1){ref-type="fig"}, flowchart).

Eventually, only 5 (11%) out of 45 patients fulfilled criteria for SIADH, among those with plasma osmolality data. Three patients with HN and hypo-osmolality had urine sodium \<40 mmol/L, but had a urine osmolality of \>100 mOsm/kg. Consequently, they were not classified as SIADH. Features of patients with probable or confirmed SIADH are depicted in [Table 2](#T2){ref-type="table"}. No significant differences were found in terms of hospitalization, compared with the rest of patients with HN (data available on request).

###### 

Features of the five hyponatremic patients with possible or probable syndrome of inappropriate antidiuretic hormone secretion

                                                       Patient \#70   Patient \#35   Patient \#80   Patient \#84   Patient \#36
  ---------------------------------------------------- -------------- -------------- -------------- -------------- --------------
  Serum sodium (mmol/L)                                132            131            132            133            125
  Serum sodium after correction for proteins (mEq/L)   133            N/A            133            134            126
  Serum glucose (mg/dL)                                42             124            82             142            87
  Plasma Osmolality (mOsmol/kg)                        271            273            274            274            266
  Urine Sodium (mmol/L)                                60             140            88             43             46
  Urea (mg/dL)                                         26             15             23             18             N/A

In regards to urine sodium, 15 out of 16 patients with HN and hypo-osmolality had excretion fraction of sodium (EFNa) less than 1%. A total of 19 (51%) out of 37 patients with HN and available measurements of urine sodium had urine sodium \<20 mmol/L. We did not find significant differences in age (P=0.66), hemoglobin (P=1), creatinine (P=0.64), temperature (P=0.75), respiratory rate (P=0.54), days of fever (P=0.75) or urea (P=0.87) between patients with urine sodium levels \<20 mmol/L and patients with urine sodium levels \>20 mmol/L.

We found a significant, negative, linear correlation between serum sodium (after correcting protein levels) and CRP (P\<0.001, Spearman r=--0.48, 95% CI: --0.61 to --0.32. We also found a negative linear correlation between serum sodium and PCT (P\<0.001, Spearman r=--0.53, 95% CI: --0.66 to --0.37. The Spearman rho for the linear correlation between CRP and PCT is 0.56 (95% CI: 0.40 to 0.69, P\<0.001), between CRP and WBC is 0.32 (95% CI: 0.17 to 0.47, P\<0.001) and between CRP and neutrophils is 0.38 (95% CI: 0.21 to 0.52, P\<0.001).

We also found a significant linear correlation between urine sodium and serum sodium (P\<0.01, Spearman r=0.3, 95% CI: 0.13 to 0.46).

CRP and PCT tend to increase as serum sodium decreases ([Figures 2](#F2){ref-type="fig"} and [3](#F3){ref-type="fig"}). Urine sodium tends to decrease as serum sodium decreases ([Figure 4](#F4){ref-type="fig"}). The correlation of determination and p values are shown in the figures. In the conditional, multivariate logistic regression model, only gender (being male) and CRP \> 100 mg/L remained as independent, significant risk factors for HN ([Table 3](#T3){ref-type="table"})

![Scatter plot of the regression analysis between serum sodium and C-reactive protein. The slope of the regression line was significantly greater than zero, indicating that PCR levels tend to increase as serum sodium levels decrease (slope=--18.66, 95% CI, --25.07 to --12.25).](pxy00302){#F2}

![Scatter plot of the regression analysis between serum sodium and procalcitonin. The slope of the regression line was significantly greater than zero, indicating that Procalcitonin (PCT) levels tend to increase as serum sodium levels decrease (slope=--1.26, 95% CI, --2.22 to --0.31).](pxy00303){#F3}

![Scatter plot of the regression analysis between serum sodium and urine sodium. The slope of the regression line was significantly greater than zero, indicating that urine sodium levels tend to decrease as serum sodium levels decrease (slope=5.12, 95% CI, 1.66 to 8.58).](pxy00304){#F4}

###### 

Report of the multiple logistic regression model with the two explanatory variables. A total of 72% of patients are explained by the model. The model's goodness of fit: R^2^ (Cox and Snell) was 0.2 and R^2^ (Nagelkerke) was 0.27.

  Variable          Coefficient (β)   Standard error   Wald X2   P value   Odds ratio   95% CI
  ----------------- ----------------- ---------------- --------- --------- ------------ -----------
  Male              1.02              0.38             7.02      0.008     2.7          1.3--5.9
  PCR \> 100 mg/L   1.8               0.38             22.9      \<0.001   6.4          3.0--13.7

DISCUSSION {#s14}
==========

In this study, HN at admission was closely related to inflammatory markers, hospitalization and fever, but rarely with true SIADH. Children admitted with CAP have a tendency for renal sodium avidity.

A significant number of patients with HN had pseudohyponatremia, with normal osmolality. When the laboratory uses indirect potentiometry, it is necessary to correct protein levels. For clinical conditions such as hyperproteinemia, in which the water content of plasma is decreased, indirect potentiometric techniques may give values lower than a technique that does not involve fixed-volume aliquots (direct potentiometry) ([@CIT0011]). Inflammation can be one of these situations.

Low levels of urine sodium (\<20 to 40 mmol/L, or FENa \<1%) suggest a nonrenal cause of HN. Low urine sodium levels also involve an appropriate compensating mechanism through the activation of the renin-angiotensin-aldosterone system. This is the normal response to hypo-osmolar HN with extracellular fluid depletion. Some of our patients with HN and urine sodium \<20 mmol/L may have had sodium loss and volume depletion through vomiting. Most patients with HN and hypo-osmolality had low urine sodium and FENa \<1%, which is at odds with SIADH. Volume depletion in our hyponatremic patients seemed to be mild, and was not reflected in laboratory values, in agreement with other reports ([@CIT0002]).

Vomiting is a well-known cause of vasopressin release, along with pain and stress ([@CIT0012]). Also, there is increasing evidence that IL-6 and ADH release are related. ADH has been shown to be released after injection of lipopolysaccharides, IL-1B and IL-6 ([@CIT0012]). HN and high levels of ADH have been found in other entities with significant inflammation ([@CIT0006]).

Inflammation seems clearly associated with HN ([@CIT0015],[@CIT0016]). We confirm this association and provide a quantification of the linear correlation between corrected sodium levels, CRP and PCT. We found a negative, linear correlation between serum sodium levels at admission and inflammatory markers in children hospitalized with CAP. Serum sodium decreased significantly with increasing levels of markers of inflammation. The multiple logistic regression analysis demonstrates the strength of the relationship between HN and CRP. However, the models were not good enough to predict HN alone. HN variations should be explained for further factors.

In situations of inflammation and infections, IL-6 is an endogenous pyrogen. IL-6 stimulates prostaglandin E2, which attaches to the prostaglandin receptors in the hypothalamus to produce the new temperature set point. IL-6 could also set a new osmolality set point, stimulating ADH liberation before reaching the physiological threshold of 290 mOsm/kg or 10% loss of blood volume. Our interpretation for patients with HN, hypo-osmolality and low urine sodium is that vomiting, inflammation and IL-6 may displace the ADH curve to the left. They would increase ADH liberation, leading to hypo-osmolality. On the other hand, the loss of water and sodium from vomiting lead to physiological renal sodium avidity and low urine excretion of sodium.

Only five patients in our study had clinical and laboratory criteria for SIADH. Urine sodium and FENa are usually low in children with HN and hypo-osmolality, which is incongruous with SIADH. In fact, the lower the serum sodium levels, the lower the urine sodium levels. None of the five most relevant papers about CAP-associated HN provided sodium levels in urine, preventing us from making a comparison with our study ([@CIT0002],[@CIT0016]).

This study has some limitations. The main shortcoming is the lack of data for all the patients, especially urine osmolality and total proteins. The number of patients with full data was lower than expected. However, we believe that the data gathered are enough to derive conclusions.

HN is a common finding in hospitalized children with CAP. HN is associated with longer hospitalizations and more days of fever, but SIADH is a rare event. Often, HN is an epiphenomenon related to hyperproteinemia, inflammation, restricted sodium excretion, and probably osmostate readjustment, rather than a true electrolyte misbalance. Clinicians should be cautious and investigate urinary sodium levels before diagnosing SIADH in patients with CAP.
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